FAKTOR-OPTIONSSCHEIN - PACIFIC BIOSCI. OF CALIFORNIA Share Price

Certificat

DE000MG2XW26

Market Closed - Bid/Ask 16:06:44 31/05/2024 BST After market 19:38:17
13.44 EUR +10.53% Intraday chart for FAKTOR-OPTIONSSCHEIN - PACIFIC BIOSCI. OF CALIFORNIA 12.46 -7.29%
Current month+8.19%
1 month+8.19%
Date Price Change
31/05/24 13.44 +10.53%
30/05/24 12.16 +9.55%
29/05/24 11.1 -13.42%
28/05/24 12.82 +1.42%
27/05/24 12.64 -0.55%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 04:06 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Issuer Morgan Stanley
WKN MG2XW2
ISINDE000MG2XW26
Date issued 24/04/2024
Strike 0.9703 $
Maturity Unlimited
Parity 0.07 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 20.18
Lowest since issue 7.33
Spread 0.26
Spread %2.04%

Company Profile

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
Sector
-
More about the company

Ratings for Pacific Biosciences of California, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Pacific Biosciences of California, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
1.94 USD
Average target price
4.682 USD
Spread / Average Target
+141.33%
Consensus